THE STONEDEAN PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: K82617 | MILTON KEYNES, MK11 1YA
Showing results 51-100 of 489
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Doxycycline hyclate | 550 | 7,070 | £681 | +7.3% ▲ |
| Mirtazapine | 503 | 12.2K | £441 | -70.6% ▼ |
| Folic acid | 501 | 19.2K | £415 | -61.4% ▼ |
| Clopidogrel | 499 | 25.2K | £800 | -70.3% ▼ |
| Nitrofurantoin | 489 | 6,438 | £2.8K | +2.5% ▲ |
| 480 | 66.4K | £2.5K | +1.2% vs avg | |
| Bendroflumethiazide | 447 | 24.7K | £397 | -42.2% ▼ |
| Allopurinol | 446 | 30.1K | £658 | -56.7% ▼ |
| Quetiapine | 439 | 15.8K | £3.5K | -29.5% ▼ |
| Ferrous sulfate | 439 | 29.3K | £959 | -14.6% ▼ |
| Sildenafil (Erectile Dysfunction) | 430 | 2,808 | £414 | -14.7% ▼ |
| Candesartan cilexetil | 429 | 23.1K | £1.1K | -63.8% ▼ |
| Indapamide | 426 | 23.2K | £669 | -50.6% ▼ |
| Alendronic acid | 424 | 2,720 | £619 | -43.5% ▼ |
| Ezetimibe | 421 | 19.5K | £3.4K | -40.8% ▼ |
| Finasteride | 408 | 21.0K | £734 | -37.7% ▼ |
| Hydrocortisone | 402 | 11.6K | £1.8K | -10.3% ▼ |
| Budesonide | 401 | 630 | £11.2K | -26.0% ▼ |
| Duloxetine hydrochloride | 390 | 12.3K | £1.0K | -38.6% ▼ |
| Gliclazide | 389 | 22.8K | £650 | -54.3% ▼ |
| Alginic acid compound preparations | 371 | 191.3K | £3.3K | -36.7% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 364 | 31.9K | £1.3K | +18.8% ▲ |
| Methotrexate | 357 | 6,940 | £6.9K | +9.7% ▲ |
| Ferrous fumarate | 345 | 27.9K | £911 | -52.4% ▼ |
| Esomeprazole | 342 | 18.6K | £1.6K | -15.5% ▼ |
| 336 | 353 | £570 | +52.5% ▲ | |
| Insulin aspart | 332 | 2,000 | £13.6K | -12.8% ▼ |
| Desogestrel | 327 | 67.3K | £1.8K | -17.5% ▼ |
| Sumatriptan succinate | 317 | 2,716 | £966 | -10.5% ▼ |
| Lidocaine hydrochloride | 314 | 1,274 | £920 | +82.0% ▲ |
| Spironolactone | 313 | 11.5K | £841 | -41.9% ▼ |
| Semaglutide | 307 | 6,861 | £30.0K | +27.5% ▲ |
| Baclofen | 306 | 29.4K | £709 | +52.8% ▲ |
| Rosuvastatin calcium | 295 | 13.9K | £437 | -67.1% ▼ |
| Famotidine | 290 | 12.1K | £7.1K | -40.6% ▼ |
| Mesalazine (Systemic) | 290 | 26.4K | £15.8K | +21.1% ▲ |
| Isosorbide mononitrate | 290 | 15.8K | £2.0K | -56.1% ▼ |
| Tirzepatide | 284 | 326 | £31.3K | +46.2% ▲ |
| Eplerenone | 278 | 8,897 | £1.1K | +4.8% ▲ |
| Lamotrigine | 278 | 22.5K | £1.2K | -52.9% ▼ |
| Melatonin | 277 | 15.3K | £4.0K | -16.7% ▼ |
| Sacubitril/valsartan | 275 | 14.9K | £24.4K | +14.8% ▲ |
| Progesterone | 271 | 22.4K | £4.3K | -35.3% ▼ |
| Fluticasone furoate | 265 | 323 | £2.2K | +36.8% ▲ |
| Hyoscine butylbromide | 264 | 26.2K | £1.8K | +13.3% ▲ |
| 264 | 30.9K | £2.0K | +22.1% ▲ | |
| Atenolol | 263 | 12.4K | £273 | -56.4% ▼ |
| Promethazine hydrochloride | 258 | 8,161 | £951 | -27.8% ▼ |
| Mometasone furoate | 256 | 296 | £2.3K | -36.2% ▼ |
| Mebeverine hydrochloride | 254 | 27.5K | £1.2K | -18.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.